Archive →
Daily Morning Briefing

Tuesday, 5 May 2026

Markets & geopolitics — ceasefire cracks, oil rips
Europe/Rome 06:00 · European cash open setup · Asia mid-session

Top of the morning

Markets snapshot

Live levels lifted from the Bloomberg Europe ticker just before 06:00 Rome. Asia / oil / FX cross-checked against Reuters, FT, CNBC. EU cash open in roughly three hours.

InstrumentLastChange / context
S&P 500 (live)7,203.94+0.36% · grinding higher despite Hormuz
Nasdaq Composite25,083.68+0.12% · tech holding the highs
Bloomberg 500 (B500)2,600.31+0.33%
FTSE 10010,363.93+0.14% · energy bid
Nikkei 225post-Greenery Day reopen, mid-session
Hang Seng / mainlandchoppy, China sanctions-defiance overhang
US 10y Treasury4.44%unchanged · curve a touch steeper
EUR/USD1.17+0.18% · ECB hike pricing back in
GBP/USD1.35+0.32%
Brent crude (CO1)~$110+5.3% · Hormuz fire-fight
WTI crude (CL1)$105.28+3.28%
Gold$4,532.10+2.42% · safe-haven bid

Geopolitics & oil

The simple read on the morning: the ceasefire is broken in everything but name. CENTCOM has confirmed an active engagement in the Strait, Iran has fired on the UAE, and Treasury is publicly pressing China and the wider coalition to commit to the US operation. Maersk's vessel-extraction under naval escort and its planning around a permanent Hormuz-bypass route are the practical signals that shipping is no longer pricing this as a transient disruption — and oil markets agree, with the +3% to +5% rip across the crude complex. Expect the war-risk premium to stay rebuilt into the European session, with the obvious trade being long energy and defence, short transport-exposed European industrials.

The European theatre adds two angles. Brussels has counter-measures ready on Trump's auto-tariff threat but is publicly asking for restraint; the auto basket is the cleanest equity proxy at the open. And Moscow's unilateral 9 May ceasefire-with-warning frames the next four days for Kyiv. From a Rome perspective the Meloni government's Azerbaijan energy play is the relevant local sub-plot — Italy is positioning ahead of any further Middle-East supply disruption.

Central banks & rates

Pendulum has swung visibly hawkish on the ECB side over the last 24 hours. Kazimir called June "all but inevitable", Nagel separately said the case for a hike exists even without further inflation evidence. The euro-zone consumer-inflation expectations survey reads upside risk as transitory but the policymakers are clearly looking through it. The cleanest expression remains the front of the EUR curve and the Bund-Treasury spread, which is tightening this morning.

On the Fed side, Williams stayed dovish — rates will need to be lower "at some point" — and on the Hill the DOJ's Pirro is asking a judge to toss the earlier ruling on Fed subpoenas, keeping the political pressure on the institution alive. The diary today: US JOLTS March job openings, S&P Services PMI April final; the bigger event remains Friday's payrolls. Lower-for-longer at the front, structurally steeper at the back, with energy now adding back to the inflation hedge bid.

Big Tech, AI & Wealth

The week's AI-capex thread keeps building. The reported White House push for pre-release model vetting would be a meaningful regulatory shift if it materialises — likely positive for incumbent labs with existing safety infrastructure, friction-creating for open-source releases. Brockman's $30bn personal mark on his OpenAI stake is the cleanest public valuation update in months and useful for benchmarking the rest of the private-AI cohort. Cerebras leading the AI-infra IPO queue ahead of a potential SpaceX listing keeps the supply pipeline dense.

Around the edges: Apollo's Zito argued credit is the safer place in a high-volatility regime; Blackstone's Jon Gray sees AI driving a "huge boom" in blue-collar work; Bloomberg flags an AI-driven hidden uplift to Northeast US power bills — the same demand-side story showing up in retail electricity. RBC is launching a public debt fund as retail investors rotate out of private credit. Apple is reportedly opening up the Wallet Pass system in iOS 27 — small but a real ecosystem signal.

Health & science (worth a glance)

Two threads relevant to a clinician this morning. First, Bloomberg Opinion published a piece on psychedelics' arrival in mainstream medicine and the risks coming with it — useful framing for the broader interventional-psychiatry pipeline that keeps re-rating on every readout. Second, a Big Take on ABA, America's most-used autism therapy and also its most controversial — relevant from a clinical-ethics and commercialisation angle as private equity continues consolidating the space. Tangential but interesting: Bloomberg flagged the FDA's internal turmoil under Marty Makary in a long-form piece — worth a skim for the regulatory backdrop on drug approvals through the rest of the year.

Today's calendar (CET)